Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

5.11
Delayed Data
As of May 05
 -0.33 / -6.07%
Today’s Change
4.75
Today|||52-Week Range
13.50
-34.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues47.1M0.00165.0M109.1M
 
 
 
 
Depreciation And Amortization1.6M1.8M1.8M2.3M
 
 
 
 
 
 
Operating ExpensesGross Income45.5M-1.8M----
 
 
 
General Expenses144.8M125.9M171.1M233.9M
 
 
 
 
 
Research And Development118.6M97.9M143.6M199.1M
 
 
 
 
 
Total Operating Expenses146.5M127.7M172.9M236.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-99.4M-127.7M-7.9M-127.1M
 
 
 
 
 
Extraordinary Credit46.6M0.000.000.00
 
 
Interest Expense On Debt1.9M0.009.6M1.4M
 
 
 
 
Other Expenses193.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-54.0M-126.8M-17.2M-128.0M
 
 
 
 
 
Income Taxes0.000.00-183.0K-335.0K
 
 
 
Net Income-54.0M-126.8M-17.4M-128.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.7M47.9M48.6M49.1M
 
 
 
 
 
Shares To Calculate EPS Diluted31.7M47.9M48.6M49.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.70-$2.64-$0.36-$2.62
 
 
 
 
 
EPS Diluted-$1.70-$2.64-$0.36-$2.62